Document Detail

Drugs to promote sinus rhythm reversion and maintenance in atrial fibrillation--why amiodarone is better.
MedLine Citation:
PMID:  12916518     Owner:  NLM     Status:  MEDLINE    
Stanley Nattel
Related Documents :
15671648 - Qt-screen: high-throughput cardiac safety pharmacology by extracellular electrophysiolo...
17467628 - Further evidence of inherited long qt syndrome gene mutations in antiarrhythmic drug-as...
12052668 - Cardiotoxicity of new antihistamines and cisapride.
3919448 - Mexiletine: long-term follow-up of a patient with prolonged qt interval and quinidine-i...
22649708 - Inhibition of dna gyrase by levofloxacin and related fluorine-containing heterocyclic c...
8064788 - Clinical pharmacology of converting enzyme inhibitors, calcium channel blockers and diu...
Publication Detail:
Type:  Comment; Comparative Study; Editorial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy     Volume:  17     ISSN:  0920-3206     ISO Abbreviation:  Cardiovasc Drugs Ther     Publication Date:  2003 Jan 
Date Detail:
Created Date:  2003-08-13     Completed Date:  2003-12-02     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8712220     Medline TA:  Cardiovasc Drugs Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  5-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amiodarone / therapeutic use*
Anti-Arrhythmia Agents / therapeutic use*
Atrial Fibrillation / drug therapy,  physiopathology,  therapy*
Calcium Channel Blockers / therapeutic use
Diltiazem / therapeutic use
Electric Countershock
Randomized Controlled Trials as Topic
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 0/Calcium Channel Blockers; 1951-25-3/Amiodarone; 42399-41-7/Diltiazem
Comment On:
Cardiovasc Drugs Ther. 2003 Jan;17(1):31-9   [PMID:  12843685 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Medication safety issue brief. Creating an alert and active team. Series II, Part 2.
Next Document:  Low-dose flecainide infusion followed by oral pilsicainide is highly effective and safe for paroxysm...